Biotech · Private company
Estetra
Track this companyFree. Adds Estetra to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- 15 mg E4/3 mg DRSPPhase 3 · ContraceptionClinicalTrials.gov · fetched Nov 12, 2026
- EstetrolPhase 3 · Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- Estetrol oral tabletPhase 3 · Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- ProgesteronePhase 3 · Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- EstetrolPhase 2 · Sexual Dysfunction, PhysiologicalClinicalTrials.gov · fetched Nov 12, 2026
- Estetrol 100 mgPhase 1 · Prolonged QTc IntervalClinicalTrials.gov · fetched Nov 12, 2026
- Estetrol 20 mgPhase 1 · Prolonged QTc IntervalClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin 400 mgPhase 1 · Prolonged QTc IntervalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal WomenPHASE2 · COMPLETED · started Jan 29, 2024ClinicalTrials.gov NCT06308614 · fetched Nov 12, 2026
- Effect of Estetrol Monohydrate (E4) on QTc IntervalPHASE1 · COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT04819906 · fetched Nov 12, 2026
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)PHASE3 · COMPLETED · started Dec 30, 2019ClinicalTrials.gov NCT04209543 · fetched Nov 12, 2026
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)PHASE3 · COMPLETED · started Sep 27, 2019ClinicalTrials.gov NCT04090957 · fetched Nov 12, 2026
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada StudyPHASE3 · COMPLETED · started Aug 30, 2016ClinicalTrials.gov NCT02817841 · fetched Nov 12, 2026